On March 17th, the US Food and Drug Administration (FDA) issued a marketing denial order (MDO) for two mint-flavored electronic cigarette products under the Vuse Solo brand, owned by RJ Reynolds Vapor Co.
The FDA has announced that the "Vuse Replacement Cartridge Menthol 4.8% G1" and "Vuse Replacement Cartridge Menthol 4.8% G2" must be removed from retail shelves. If these products continue to be sold in the United States, the company will face FDA enforcement action.
However, a spokesperson for British American Tobacco (BAT), the parent company of RJ Reynolds Vapor Co., stated that the company plans to immediately seek an injunction to allow the product to continue being sold while awaiting further review.
Reference:
on a Food and Drug Administration (FDA) decision to remove certain flavored e-cigarettes from the market until the company has exhausted all its appeal options. 【1】British American Tobacco, the parent company of R.J. Reynolds Vapor, announced that it plans to request a postponement of the Food and Drug Administration's (FDA) decision to ban specific flavored e-cigarettes until the company has utilized all possible avenues of appeal.
This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.
